A 8075 New York Assembly · 2023 Regular Session

Relates to the availability of opioid reversal agents

Summary

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Bill status passed 3 of 5 stages cleared

Introduction

Sep 2023

Committee Review

Jun 2024

Assembly Passage

Jun 2024

Senate Passage

Governor

Introduced Sep 27, 2023 Last action Jun 7, 2024

Floor votes · Assembly Jun 7, 2024

How they voted

141–1

Passed · 6 other

Total votes 148

Jun 7, 2024

D Democratic101

96 Yea 5

95% Yea

R Republican47

45 Yea 1 Nay 1

95% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Jun 7, 2024

Committee

REFERRED TO RULES

upper

Jun 7, 2024

Lower · Passed

PASSED ASSEMBLY

lower

Jun 5, 2024

Committee

REPORTED REFERRED TO RULES

lower

Jun 3, 2024

Lower · Passed

PRINT NUMBER 8075D

lower

Jun 3, 2024

Lower · Passed

AMEND AND RECOMMIT TO WAYS AND MEANS

lower

Apr 9, 2024

Committee

REPORTED REFERRED TO WAYS AND MEANS

lower

Jan 30, 2024

Lower · Passed

PRINT NUMBER 8075C

lower

Jan 30, 2024

Lower · Passed

AMEND (T) AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE

lower

Jan 3, 2024

Committee

REFERRED TO ALCOHOLISM AND DRUG ABUSE

lower

Oct 27, 2023

Lower · Passed

PRINT NUMBER 8075B

lower

Oct 27, 2023

Lower · Passed

AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE

lower

Oct 11, 2023

Lower · Passed

PRINT NUMBER 8075A

lower

Oct 11, 2023

Lower · Passed

AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE

lower

Sep 27, 2023

Committee

REFERRED TO ALCOHOLISM AND DRUG ABUSE

lower

1 primary · 14 co-sponsors